Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results

Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results  Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – May 10, 2018 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Rett…